Becton Dickinson (BDX) Stock 2026 Review

Becton Dickinson4.5/5

BDX (NYSE)

Dividend yield
2.02%
Distribution
Quarterly
1-Year Return
23.39%
5-Year Return
19.64%

Becton Dickinson (BDX) stands out as a high-quality Dividend Aristocrat, boasting a robust economic moat and a long track record of increasing dividends for 50 consecutive years. With a dividend yield of approximately 2.02% and an impressive one-year return of 23.39%, it remains an attractive choice for income-focused investors. Analysts are optimistic, with a consensus rating of Buy and a median 12-month price target of $202, suggesting potential upside ahead.

Pros:

  • Strong dividend growth history
  • High-quality medical technology

Cons:

  • Market volatility risk
  • Potential margin pressures

Becton Dickinson (BDX) may be particularly suitable for income-focused investors seeking stability and growth, given its strong dividend history and solid financial performance. With a proven track record and positive analyst outlook, it represents a compelling option for those looking to balance income generation with capital appreciation in the healthcare sector.

Frequently Asked Questions

Related Guides